Osteoarthritis (OA) is one of the most common diseases, which affect the correct functionality of synovial joints and is characterized by articular cartilage degradation. Limitation in the treatment of OA is mostly due to the very limited regenerative characteristic of articular cartilage once is damaged. Small animal models are of particular importance for mechanistic analysis to understand the processes that affect cartilage degradation. Combination of joint injury techniques with the use of stem cells has been shown to be an important tool for understanding the processes of cartilage degradation and regeneration. Implementation of stem cells and small animal models are important tools to help researchers to find a solution that could ameliorate and prevent the symptoms of OA.
| INTRODUCTION
Healthy hyaline articular cartilage is crucial for the proper functioning of the joint, providing a resilient and low-friction surface for smooth articulation, also capable of absorbing shocks due to mechanical loading. [1] [2] [3] [4] Osteoarthritis (OA) is a joint disease characterized by enzymatic breakdown of proteoglycan and collagen and eventual loss of the cartilage of the articular surface. This causes bone ends to grind against each other, impairing movement because of acute and chronic pain, swelling, and stiffness of the joints, and it can involve an immunological response. [5] [6] [7] In most cases, treatment is restricted to perform joint replacement, partial or total. 8 Limitation in the treatment of OA is mostly due to the very limited regenerative characteristic of articular cartilage once it is damaged. 3, 9 Recently, the assumption that articular cartilage is a nonregenerative tissue has been challenged, and new evidences suggest the presence of prechondrocytes, which could be used for regeneration and OA treatment.
Stem cells (SCs) are clonogenic and characterized by 2 main features: multipotency (the ability to differentiate into different types of cells) and self-renewal (the ability of replenishing the SC population). 10 As early as 1966, Friedenstein and colleagues showed that cells isolated from the bone marrow can differentiate into adipocytes, chondrocytes, osteoblasts, and reticulocytes. 11 Stem cells in the joint have been identified in different tissues, not only in the stromal compartment of the bone marrow. The superficial zone has been hypothesized to harbor SCs and expression of SC markers has been shown (Notch-1, Stro-1, and vascular cell adhesion-1). 12, 13 Notch-1 positive cells isolated from the superficial zone of the articular cartilage retain high-colony-forming efficiency, 14 a characteristic of SCs, which was abolished once Notch signaling was inhibited. 15 Synovium might harbor SCs as the synovial membrane rapidly becomes hyperplastic when subjected to injuries or trauma, [16] [17] [18] and multipotent SCs have been isolated from adult human synovium and expanded, showing limited senescence and maintaining the multilineage potency. 19 Another structure that has been suggested to be a reservoir for SCs or prechondrocytes is the groove of Ranvier, which was first described in 1873 and was shown to contain proliferating cells, which express markers specific and typical for progenitors and SCs, such as Stro-1, Ptch-1, Jagged-1, N-cadherin, and FGFR3. 20, 21 Moreover, since 2003, several groups have demonstrated the ability of chondrocytes to generate in vitro multilineage potency and differentiate into chondrogenic, adipogenic, and osteogenic lineage. [22] [23] [24] [25] A schematic representation of where SC niches have been identified in the joint is depicted in Figure 1 .
This review will particularly focus on the progress that has been done thanks to small animal models and on the implementation of recruitment and injection of SC in different mouse models for the study of a therapy for OA.
| WHY ANIMAL MODELS ARE USEFUL TO UNDERSTAND OA
The use of animal models is of critical importance to promote transla- 56, 57 In the DMM model, the mice developed mild-to-moderate OA, and although the severity of the lesions increased over time, posterior erosion of the tibial plateau, as for the ACLT model, was never observed.
Also, neocondrogenesis was significant in the ACLT model while absent in the DMM, as well as free cells in the synovial cavity. 57 The DMM model appears to be more similar to the slow degradation of OA in human compared to the ACLT model. Moreover, it has been successfully used in different strains of knock-out (KO) mice to understand the progression of OA and the role of those genes in the process, such as [92] [93] [94] to MMP13, whose ablation had negative effects on the progression of OA, suggesting that a balance between degradation and regeneration is crucial in maintaining cartilage integrity. 41, 58 Clements et al 40 analyzed a model similar to the one proposed by authors with surgical models of OA, 64 although it could not inhibit inflammation and macrophage invasion of the synovium. 65 Christiansen et al described the use of a single heavy load compression of the tibia in young C57BL/6 mice to mimic acute joint injury in human, 66 similarly to experiments performed in rabbits. These results strongly support the existence of a certain cell type, which can promote good healing of articular defects. Although it might be argued that results derived from these types of studies cannot be translated to the clinic, as good repair is observed only in young mice while patients with articular defects are usually adults, they still can be very useful to identify the best type of cell to promote repair. Young mice offer the best model to study the mechanisms of repair as they were able to develop hyaline cartilage, while juveniles formed fibrocartilage and adults showed poor cartilage repair. 76 Similarly to Fitzgerald et al, another group compared the effect of superficial joint defects in 2 mouse strains with different healing abilities: DBA/1 and C57BL/6. 77 The lesion that they generated was highly standardized, choosing a specific site of the femur where cartilage thickness is uniform and accessible after patellar dislocation. The authors created a defect that was deeper than the full thickness of the cartilage and would run along the center of the patellar groove, ensured by the use of a glass bead together with the needle. As also observed by Kamekura et al, 56 the younger mice DBA/1 healed the surface defect while the C57BL/6 did not and developed in addition secondary OA. Different repairs in different strains are due to different regulations of cell viability and matrix remodeling. When the defect was induced in DBA/1-aged mice, they did not show repair of the lesion either, confirming that the age of the animals when the lesion occurs is a crucial factor that affects the repair. Follow-up showed positive outcome in all patients with the formation of hyaline cartilage at the site of the transplant. 86 Some issues presented themselves with this technique: of particular importance were the problems of dedifferentiation of chondrocytes into fibroblast-like cells after monolayer culture and difficulties in the positioning of the grafted cells. Therefore, different scaffolds with different collagen, polyglycolic/polylactic acid, hyaluronic acid, and fibrin gel compositions have been engineered to achieve a more uniform and reproducible repair of the lesion. [87] [88] [89] [90] [91] Follow-up of these patient cohorts has shown successful regeneration and integration of the graft and healthy cartilage appearance. [92] [93] [94] [95] [96] Although the general outcome of the repair was positive, the newly formed cartilage did not entirely resemble the native articular cartilage. [97] [98] [99] During the past few years, stromal SCs have become the best candidate for isolation, rapid expansion, and differentiation into chondrocytes. 100 Bone marrow and umbilical cord-derived SCs have been widely used in the effort of regenerate hyaline cartilage in vitro. 101 Although the use of scaffolds to promote and improve the cartilage repair in vivo showed positive outcome in various animal models, they have not been suggested for the use in human because of possible side effects. 102 Another option is the implantation of small spherical aggregates of chondrocytes, whose structure resembles that of native cartilage. 103 This approach eliminates both the use of scaffolds and the associated problems, such as toxicity, immunogenicity, differentiation due to mechanical strain forces, 104, 105 and the problem of extracellular matrix (ECM) degradation in the repair tissue. 106, 107 Further development in the use of pellet culture has been made using microspheres to induce chondrogenesis in human mesenchymal SCs (hMSCs). 108, 109 Microspheres were able to release continuously transforming growth factor b3 (TGFb3), allowing its availability in situ for hMSCs to differentiate and at the same time avoiding side effects of scaffolds, such as osteophyte formation and inflammation. 
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Horie et al performed an experiment of xenotransplantation of hMSCs into rat meniscus, and they observed that they promoted meniscal regeneration with synthesis of rat-collagen 2 although only a few of the human cells actually engrafted in the host tissue and differentiated. Also, hMSCs showed a protective effect on cartilage, demonstrated by reduced OA of the tibia when compared to the control knees. 114 Therefore, it appears that the effect of MSCs is not only limited to differentiation into chondrocytes but also can play an important role in immunomodulation and provide a trophic effect on the surrounding tissue. 115 
